PREDICTING STEADY-STATE SERUM CONCENTRATIONS OF DRUGS

[1] PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE [J]. CLINICAL PHARMACOKINETICS, 1976, 1 (06) : 389 - 405

[2] BERGNER PEE, 1973, BRIT J PHARMACOL, V49, P328, DOI 10.1111/j.1476-5381.1973.tb08380.x

[3] STUDIES OF ABSORPTION AND REMOVAL OF PROPRANOLOL IN HYPERTENSIVE PATIENTS DURING THERAPY [J]. CIRCULATION, 1975, 52 (02) : 313 - 318

[4] 24-HOUR SERUM LITHIUM LEVEL AS A PROGNOSTICATOR OF DOSAGE REQUIREMENTS [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (05) : 601 - 603

[5] CUTLER RE, 1972, J AMER MED ASSOC, V219, P1037, DOI 10.1001/jama.219.8.1037

[6] DOBBS SM, 1976, BRIT J CLIN PHARMACO, V3, P231, DOI 10.1111/j.1365-2125.1976.tb00597.x

[7] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P494

[8] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487

[9] SOME CONSIDERATIONS AS TO DETERMINATION AND SIGNIFICANCE OF BIOLOGIC HALF-LIFE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) : 624 - +

[10] Gibaldi M, 1975, PHARMACOKINETICS

[1] PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE [J]. CLINICAL PHARMACOKINETICS, 1976, 1 (06) : 389 - 405

[2] BERGNER PEE, 1973, BRIT J PHARMACOL, V49, P328, DOI 10.1111/j.1476-5381.1973.tb08380.x

[3] STUDIES OF ABSORPTION AND REMOVAL OF PROPRANOLOL IN HYPERTENSIVE PATIENTS DURING THERAPY [J]. CIRCULATION, 1975, 52 (02) : 313 - 318

[4] 24-HOUR SERUM LITHIUM LEVEL AS A PROGNOSTICATOR OF DOSAGE REQUIREMENTS [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (05) : 601 - 603

[5] CUTLER RE, 1972, J AMER MED ASSOC, V219, P1037, DOI 10.1001/jama.219.8.1037

[6] DOBBS SM, 1976, BRIT J CLIN PHARMACO, V3, P231, DOI 10.1111/j.1365-2125.1976.tb00597.x

[7] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P494

[8] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487

[9] SOME CONSIDERATIONS AS TO DETERMINATION AND SIGNIFICANCE OF BIOLOGIC HALF-LIFE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) : 624 - +

[10] Gibaldi M, 1975, PHARMACOKINETICS